)
)
Oxford Biomedica Investor Relations Material
Latest events
H1 2024
Oxford Biomedica
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Oxford Biomedica plc
Access all reports
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development and bioprocessing of cell and gene therapy products in Europe and internationally. The company's products are designed to treat diseases by replacing or enhancing a patient's defective genes with normal or healthy copies in order to restore or correct its function. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.
Key slides for Oxford Biomedica plc
H1 2024
Oxford Biomedica plc
H1 2024
Oxford Biomedica plc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
OXB
Country
🇬🇧 United Kingdom